製品名: Proparacaine hydrochloride
同義語: プロパラカインHCL;プロパラカイン塩酸塩;3-アミノ-4-プロポキシ安息香酸2-(ジエチルアミノ)エチルエステル塩酸塩;アルカイン;安息香酸,3-アミノ-4-プロポキシ-,2-(ジエチルアミノ)エチルエステル,塩酸塩;安息香酸,3-アミノ-4-プロポキシ-,2-(ジエチルアミノ)エチルエステル,一塩酸塩;ベータ-(ジエチルアミノ)3-アミノ-4-n-プロポキシ安息香酸エチル塩酸塩;chibro-heracaine
CAS: 5875-06-9
MF: C16H27ClN2O3
MW: 330.85
アイネス: 227-541-7
使用方法 麻酔薬;神経伝導阻害剤
Proparacaine hydrochloride is an ester topical anesthetic. Its mechanism of action is to reduce the instantaneous permeability of neurons to sodium, stabilize nerve cell membranes, and prevent the generation and conduction of nerve electrical impulses, thereby producing anesthesia. Block pain fibers first, then block temperature, touch, and deep sensory fibers. Thin nerve fibers are more sensitive than thick nerve fibers and take longer to recover. The anesthetic strength of this medicine is slightly higher than the same concentration of tetracaine, and the effect is fast.
Proparacaine Hydrochloride Ophthalmic Solution is indicated for topical anesthesia in ophthalmic practice. Representative ophthalmic procedures in which the preparation provides good local anesthesia include measurement of intraocular pressure (tonometry), removal of foreign bodies and sutures from the cornea, conjunctival scraping in diagnosis and gonioscopic examination; it is also indicated for use as a topical anesthetic prior to surgical operations such as cataract extraction.
| テスト項目 |
標準 |
テスト結果 |
| キャラクター |
白色の結晶性粉末 |
適合 |
| 識別 |
そして
UV
The aqueous layer responds to the tests for
塩化 |
適合
適合
適合 |
| PH |
4.5-6.0 |
5.8 |
| 重金属 |
以上ではありません 0.001% |
適合 |
| 水 |
4.0%-6.0% |
5.5% |
| 強熱時の残留物 |
以上ではありません 0.1% |
0.04% |
| Limit of residual solvents |
以上ではありません 2% |
適合 |
| クロマトグラフィー純度 |
総不純物:<2.0%
個々の不純物:<0.5% |
適合
適合 |
| アッセイ |
98.5%-101.5% |
99.50% |
| 結論 |
It conforms to USP32 standard |